Response to Letter; Discrimination between Benign and Malignant Post-SARS-CoV-2 Vaccination Lymphadenopathy is Feasible, to Our Article; Axillary Adenopathy in Patients with Recent COVID-19 Vaccination: A New Diagnostic Dilemma

Korean J Radiol. 2022 Jul;23(7):775-776. doi: 10.3348/kjr.2022.0207. Epub 2022 May 31.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19 Vaccines / adverse effects
  • COVID-19* / prevention & control
  • Humans
  • Lymphadenopathy* / diagnostic imaging
  • Lymphadenopathy* / etiology
  • SARS-CoV-2
  • Vaccination

Substances

  • COVID-19 Vaccines